| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/05/2011 | US7918843 Controllable drug delivery device |
| 04/05/2011 | US7918842 Medical device with controlled reservoir opening |
| 04/05/2011 | CA2739682A1 Topical nsaid compositions having sensate component |
| 04/05/2011 | CA2526538C Aqueous compositions for disinfection and/or sterilization |
| 04/05/2011 | CA2494695C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/05/2011 | CA2483028C Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
| 04/05/2011 | CA2474479C Composition for inhalation |
| 04/05/2011 | CA2470168C Drink preparation comprising ketoprofen and its use in the simultaneous treatment of conditions causing fever, inflammation and pain in a herd of animals |
| 04/05/2011 | CA2437788C Inflammation-inhibiting compounds |
| 04/05/2011 | CA2379776C A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids |
| 04/05/2011 | CA2330916C Triterpene compositions and methods for use thereof |
| 03/31/2011 | WO2011038278A2 Micelle encapsulation of therapeutic agents |
| 03/31/2011 | WO2011038259A1 Synthetic glycosyl hydrolase based on dna nanoweaves |
| 03/31/2011 | WO2011038116A2 Composition comprising pomegranate polyphenols for improving bone health |
| 03/31/2011 | WO2011038104A2 Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process |
| 03/31/2011 | WO2011038101A1 Manufacture of chewing gum product with radiofrequency |
| 03/31/2011 | WO2011038094A1 Manufacture of lozenge product with radiofrequency |
| 03/31/2011 | WO2011038081A1 Biodegradable foams with improved dimensional stability |
| 03/31/2011 | WO2011038073A1 Methods for the preparation of liposomes comprising docetaxel |
| 03/31/2011 | WO2011038070A1 Manufacture of tablet having immediate release region and sustained release region |
| 03/31/2011 | WO2011038068A1 Methods for the preparation of liposomes |
| 03/31/2011 | WO2011038058A1 Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder |
| 03/31/2011 | WO2011038014A2 Composition and method for treatment of diabetes |
| 03/31/2011 | WO2011037976A2 Pramipexole pharmaceutical formulations |
| 03/31/2011 | WO2011037955A1 Implant devices for modulating bioactive agent release profiles |
| 03/31/2011 | WO2011037953A2 Implant devices having varying bioactive agent loading configurations |
| 03/31/2011 | WO2011037908A1 Injectable aqueous ophthalmic composition and method of use therefor |
| 03/31/2011 | WO2011037760A2 Composite layered hemostasis device |
| 03/31/2011 | WO2011037658A1 Implantable patch and surgical kit for preparation thereof |
| 03/31/2011 | WO2011037551A2 Carrying of a combination containing tiotropium in a blister strip |
| 03/31/2011 | WO2011037549A2 Dry powder formulation of tiotropium carried in blister strip |
| 03/31/2011 | WO2011037281A1 Slow-release cilostazol tablet having an improved elution rate and minimal side effects |
| 03/31/2011 | WO2011037252A1 Liposome preparation containing spicamycin derivative |
| 03/31/2011 | WO2011037157A1 Eye drops |
| 03/31/2011 | WO2011036811A1 Turmeric pigment composition and method for preparing same |
| 03/31/2011 | WO2011036619A2 Two step ultrasound protocol for drug delivery |
| 03/31/2011 | WO2011036601A1 Acid resistant capsules |
| 03/31/2011 | WO2011036599A1 A dissolvable film strip comprising natural components |
| 03/31/2011 | WO2011036557A1 Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles |
| 03/31/2011 | WO2011036533A1 Pharmaceutical composition comprising prasugrel and triflusal |
| 03/31/2011 | WO2011036521A2 Formulations comprising triptan compounds |
| 03/31/2011 | WO2011036400A1 Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract |
| 03/31/2011 | WO2011036270A1 Pharmaceutical composition |
| 03/31/2011 | WO2011036234A1 Lipid nanocapsules, method for preparing same, and use thereof as a drug |
| 03/31/2011 | WO2011036159A2 Treatment and prevention of hiv infection |
| 03/31/2011 | WO2011036114A1 Oral pharmaceutical composition comprising diclofenac |
| 03/31/2011 | WO2011035988A1 Antiseptic ointment comprising bentonite intercalated with silver, copper or zinc for external application |
| 03/31/2011 | WO2011035905A1 Galenic formulation in a colloidal form |
| 03/31/2011 | WO2011035734A1 Relinqing extract, preparative method and use thereof |
| 03/31/2011 | WO2011016049A3 A stable composition of ready-to-use gemcitabine injection |
| 03/31/2011 | WO2011014722A3 Erodible embolization material |
| 03/31/2011 | WO2011005709A3 Transvaginal delivery of drugs |
| 03/31/2011 | WO2011004328A3 Crosslinked protein nanocrystals, crosslinked protein nanoaggregates and method of preparation thereof |
| 03/31/2011 | WO2010132882A3 Sublingual dexmedetomidine compositions and methods of use thereof |
| 03/31/2011 | WO2010122357A3 Delivery systems |
| 03/31/2011 | WO2010120905A3 Novel nano-probes for molecular imaging and targeted therapy of diseases |
| 03/31/2011 | WO2010103374A3 Oily suspension containing probiotic bacteria for paradiatric uses |
| 03/31/2011 | WO2010093528A3 On-demand and reversible drug release by external cue |
| 03/31/2011 | WO2010065456A4 Flowable pharmaceutical depot |
| 03/31/2011 | WO2010020935A8 Application on monoolein as a new helper lipid in transfection |
| 03/31/2011 | WO2009158724A3 Injectable delivery of microparticles and compos itions therefore |
| 03/31/2011 | US20110077737 Tunably Crosslinked Polysaccharide Compositions |
| 03/31/2011 | US20110077682 Hemorrhage Control Devices and Methods |
| 03/31/2011 | US20110077581 Targeted cellular delivery of nanoparticles |
| 03/31/2011 | US20110077296 Method and composition for delivering zinc to the nasal membrane |
| 03/31/2011 | US20110077217 Selectively depolymerized galactomannan polysaccharide |
| 03/31/2011 | US20110076385 Ion exchange resin treated to control swelling |
| 03/31/2011 | US20110076337 Emulsions containing arylboronic acids and medical articles made therefrom |
| 03/31/2011 | US20110076336 Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof |
| 03/31/2011 | US20110076335 Novel lipid formulations for delivery of therapeutic agents to solid tumors |
| 03/31/2011 | US20110076334 Methods and compositions for treatment of raynaud's phenomenon |
| 03/31/2011 | US20110076332 Dextran-chitosan based in-situ gelling hydrogels for biomedical applications |
| 03/31/2011 | US20110076331 Use of Deuterium Oxide as an Elastase Inhibitor |
| 03/31/2011 | US20110076330 Use of adipose tissue-derived stromal cells in spinal fusion |
| 03/31/2011 | US20110076329 Graft prosthesis, material and methods |
| 03/31/2011 | US20110076328 Compositions for the treatment of hair loss |
| 03/31/2011 | US20110076327 Herbal Pain Killer Compositions |
| 03/31/2011 | US20110076326 Modified protein excipient for delayed-release tablet |
| 03/31/2011 | US20110076325 Abuse resistant drugs, method of use and method of making |
| 03/31/2011 | US20110076324 Use of Histamine H4 antagonist for the treatment of post-operative adhesions |
| 03/31/2011 | US20110076323 Vaccine for alzheimer's disease |
| 03/31/2011 | US20110076322 Amphoteric liposomes |
| 03/31/2011 | US20110076321 Self-adhesive polymer matrix containing sea algae extract |
| 03/31/2011 | US20110076319 Bioresorbable metal stent with controlled resorption |
| 03/31/2011 | US20110076318 Retinoid-containing sustained release intraocular implants and related matters |
| 03/31/2011 | US20110076316 Scalable matrix for the in vivo cultivation of bone and cartilage |
| 03/31/2011 | US20110076314 Hydrophobic polysaccharides with silyl ether linkages having enhanced degradation and medical articles made therefrom |
| 03/31/2011 | US20110076313 Antimicrobial gas impregnated devices and methods |
| 03/31/2011 | US20110076311 Ceramide dispersion |
| 03/31/2011 | US20110076310 Antiperspirant/Deodorant Composition |
| 03/31/2011 | US20110076308 Micelle encapsulation of therapeutic agents |
| 03/31/2011 | US20110076307 Polycationic gene carriers formed of endogenous amino group-bearing monomers |
| 03/31/2011 | US20110076238 Compounds for the treatment of proliferative processes |
| 03/31/2011 | US20110076236 Compositions and methods of treatment using modulators of motoneuron diseases |
| 03/31/2011 | US20110076234 Peptides comprising an isodgr motif |
| 03/31/2011 | US20110076231 Temporary embolization using inverse thermosensitive polymers |
| 03/31/2011 | US20110073518 Generally Linear Effervescent Oral Fentanyl Dosage Form and Methods of Administering |
| 03/31/2011 | DE102009043342A1 Stoffe für selbstorganisierte Träger zur kontrollierten Freisetzung eines Wirkstoffs Materials for self-organized support for the controlled release of a drug |
| 03/31/2011 | CA2781529A1 Methods for the preparation of liposomes comprising docetaxel |
| 03/31/2011 | CA2781527A1 Methods for the preparation of liposomes |